Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Theravance Company Profile (NASDAQ:THRX)

Consensus Ratings for Theravance (NASDAQ:THRX) (?)
Ratings Breakdown: 2 Sell Rating(s), 5 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 1.88)
Consensus Price Target: $19.50 (18.47% upside)

Current Analysts' Coverage Summary for Theravance (NASDAQ:THRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/6/2015ZacksUpgradeNeutral -> Outperform$24.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2015Bank of AmericaBoost Price Target$17.00ViewTweet This Rating  Share This Rating on StockTwits
12/2/2014Leerink SwannDowngradeOutperform -> Market Perform$17.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2014Robert W. BairdDowngradeNeutral -> UnderperformViewTweet This Rating  Share This Rating on StockTwits
7/24/2014Morgan StanleyDowngradeBuy -> Neutral$34.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
7/21/2014Stifel NicolausDowngradeUnderweight$12.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
6/12/2014Citigroup Inc.DowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
7/19/2013Sanford C. BernsteinBoost Price TargetMarket Perform$30.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013S&P Equity ResearchBoost Price TargetBuy$32.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/30/2013 forward)